Dr Antolin's team focused on computational chemical biology methods and resources applied to translational cancer research and drug discovery. Dr Antolin left the ICR in September 2022 and the team will be closed.
Dr Albert Antolin led the Systems Chemical Biology Team. His team aimed to develop public chemical biology resources, uncover how drugs work at a systems level and develop computational methods to design multi-target drugs that tackle cancer drug resistance. Dr Albert Antolin left the ICR in September 2022.